Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Research And Trials

CRISPR genome editing and immunotherapy – the early adopter

How is CRISPR genome editing helping harness the power of immunotherapy?

Taking advantage of cancers’ abnormal metabolism could lead to a new way to ‘starve’ tumours

Our researchers in Glasgow might have found a way to shut down certain cancer cells’ fuel supply with a specially designed diet.

Targeting cancer spread: keeping breast tumours under LOX and key

Find out how our scientists are developing a way to target a troublesome cancer molecule, LOX.

News digest – immunotherapies showing promise, breast cancer drug approved for Scotland, childhood cancer rates, and… killer sofas?

Immunotherapies are showing promise but not for every tumour, calls for boys to be vaccinated against HPV, and... what's killer about sofas? Find out in the news digest....

Blood tests, microbes, immunotherapy and more: AACR 2017’s hottest topics

At AACR 2017, thousands of doctors and scientists shared progress in cancer research. Read about the hottest topics.

Study suggests why an immunotherapy drug works in some melanoma patients but not in others

Matching tumour size to the body’s immune response could help doctors tailor immunotherapy treatments for melanoma patients whose disease has spread.

News digest – cutting sugar, a new NHS target, lab-grown mini tumours, and… vitamin C as a treatment?

New guidelines to help cut sugar levels, old and new cancer waiting targets, tools to improve diagnosis, and... why is vitamin C in the headlines? We explain all in the...

Reports that cancer is ‘mainly bad luck’ make a complicated story a bit too simple

New research predicts that 2 in 3 cancers are ‘due to bad luck’, we look at why the story is a bit more complicated than that.

Giving pancreatic cancer patients better opportunities to join clinical trials

We're backing a new project that could boost our understanding of pancreatic cancer and increase opportunities for patients to join clinical trials.

Pages